BDX News and Press, Becton Dickinson and Company From 05/20/22

Abbott is dealing with some significant pressure due to the baby formula shortage. The shares of Abbott are trading for a price 22% lower than the 52 weeks high. However, the current valuation with the uncertainty regarding baby formula and Covid testing makes Abbott less attracti...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips ABM Industries ( ABM ): Though relatively small in size, ABM Industries is one of top names in its industry. Becton, Dickinson & Co.  ( BDX ) has grown from humble beginnings to be one of the lar...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

Healthcare equipment and Medical Devices sector stood out during the covid-19 pandemic crisis and delivered strong returns over the medium and long term. Stocks from healthcare equipment and Medical Devices sector have performed poorly over the past one month, resulting in steep price...

BD Launches Fully Automated, High-Throughput Infectious Disease Molecular Diagnostic Platform in the U.S. PR Newswire 510(k) Clearance of BD COR™ MX Instrument Elevates Standard of Care for Sexually Transmitted Infections FRANKLIN LAKES, N.J. ,...

Babson, BD Expand Strategic Partnership to Advance Diagnostic Blood Collection in New Care Settings PR Newswire Expanded Collaboration Agreement to Make Less Invasive Blood Sample Collection More Convenient and Patient Centered AUSTIN, Texas and FRANK...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Now that the country looks more normal than ever since the start of the pandemic, people need to take care of their health holistically, which could benefit these dental stocks to buy. Henry Schein ( HSIC ): North ...

The following slide deck was published by Becton, Dickinson and Company in conjunction with their 2022 Q2 earnings call. For further details see: Becton, Dickinson and Company 2022 Q2 - Results - Earnings Call Presentation

Becton, Dickinson and Company (BDX) Q2 2022 Earnings Conference Call May 05, 2022, 08:00 AM ET Company Participants Francesca DeMartino - SVP, IR Thomas Polen - President, CEO & Chairman Christopher DelOrefice - EVP & CFO Simon Campion - EVP & President, Interventional Segment Con...

Becton, Dickinson press release (NYSE:BDX): Q2 Non-GAAP EPS of $3.18 beats by $0.23. Revenue of $5.01B (+2.0% Y/Y) beats by $230M. On a pre-spin basis, which includes the results of the Diabetes Care business: The company now expects fiscal year 2022 revenues to be in the range of approx...